Physician profile
Alberto Cadena
NPI 1710074182
$47,759.90
in general payments reported to CMS, 2019-2025
14 companies · $19.20 in 2025
The $19.20 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $24K · 2021: $1,211 · 2025: $19.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $19.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $19.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $25,462.50 | 2020-2021 | |
| Shire North American Group INC | $21,907.00 | 2019 | |
| Intuitive Surgical, INC. | $81.73 | 2019 | |
| Mayne Pharma Commercial LLC | $45.11 | 2021 | |
| Abbvie INC. | $41.72 | 2019-2021 | |
| Organon LLC | $38.95 | 2021-2025 | Jada System |
| Daiichi Sankyo INC. | $34.80 | 2019-2021 | |
| Lupin INC. | $34.61 | 2021 | |
| Conmed Corporation | $33.33 | 2019 | |
| Hologic Sales and Service, LLC | $20.79 | 2021 | |
| Covidien LP | $19.05 | 2019 | |
| Coopersurgical, INC. | $16.31 | 2021 | |
| Allergan, INC. | $12.48 | 2019 | |
| Avion Pharmaceuticals | $11.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alberto Cadena listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.